Monoamine oxidase B, smoking, and Parkinson's disease
- 1 February 1986
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 72 (2-3), 265-272
- https://doi.org/10.1016/0022-510x(86)90014-6
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouseNeuroscience Letters, 1985
- Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouseNeuroscience Letters, 1985
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not destroy nigrostriatal neurons in the scorbutic guinea pigLife Sciences, 1985
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Chronic Parkinsonism Secondary to Intranasal Administration of a Product of Meperidine-Analogue SynthesisNew England Journal of Medicine, 1984
- ?-Carbolines as selective monoamine oxidase inhibitors:In vivo implicationsJournal of Neural Transmission, 1982
- Low platelet monoamine oxidase activity in cigarette smokersLife Sciences, 1981
- Elevation of Brain GABA Content by Chronic Low‐Dosage Administration of Hydrazine, a Metabolite of IsoniazidJournal of Neurochemistry, 1981
- The effect of age on the activity and molecular properties of human brain monoamine oxidaseJournal of Neural Transmission, 1980
- Chemical studies on tobacco smoke. Quantitative analysis of hydrazine in tobacco and cigarette smokeAnalytical Chemistry, 1974